Can tocilizumab decrease cartilage oligomeric matrix protein levels and disease activity in patients with long-standing rheumatoid arthritis? [electronic resource]
Producer: 20151130Description: 131-5 p. digitalISSN:- 1875-6360
- Aged
- Antibodies, Monoclonal, Humanized -- pharmacology
- Antirheumatic Agents -- therapeutic use
- Arthritis, Rheumatoid -- blood
- Biomarkers -- blood
- Cartilage Oligomeric Matrix Protein -- blood
- Enzyme-Linked Immunosorbent Assay
- Female
- Humans
- Male
- Middle Aged
- Receptors, Tumor Necrosis Factor -- therapeutic use
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.